SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Gajda T) "

Sökning: WFRF:(Gajda T)

  • Resultat 1-7 av 7
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • 2019
  • Tidskriftsartikel (refereegranskat)
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  • Powell, KJ, et al. (författare)
  • Chemical speciation of Hg(II) with environmental inorganic ligands
  • 2004
  • Ingår i: AUSTRALIAN JOURNAL OF CHEMISTRY. - 0004-9425. ; 57:10, s. 993-1000
  • Tidskriftsartikel (refereegranskat)abstract
    • Complex formation between Hg(II) and the common environmental ligands Cl-, OH-, CO32-, SO42-, and PO43- can have profound effects on Hg(II) speciation in naturalwaters with low concentrations of organic matter. Hg(II) is labile, so its distribution among these inorganic ligands can be estimated by numerical modelling if reliable values for the relevant stability constants are available. A summary of critically reviewed constants and related thermodynamic data is presented. Recommended values of log(10) beta(p,q,r)(o) and the associated reaction enthalpies, Delta(r)H(m)(o), valid at I-m = 0 mol kg(-1) and 25degreesC, along with the equations and specific ion interaction coefficients required to calculate log(10) beta(p,q,r) values at higher ionic strengths and other temperatures are also presented. Under typical environmental conditions Hg(II) speciation is dominated by the reactions Hg2+ + 2Cl(-) reversible arrow HgCl2(aq) (log(10) beta(2)(o) = 14.00 +/- 0.07), Hg2+ + Cl- + H2O reversible arrow Hg(OH) Cl(aq) + H+ (log(10) beta(o) = 4.27 +/- 0.35), and Hg2+ + 2H(2)O reversible arrow Hg(OH)(2(aq)) + 2H(+) (log(10)* beta(2)(o) =- 5.98 +/- 0.06).
  •  
7.
  • Waszczuk-Gajda, A, et al. (författare)
  • Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study
  • 2022
  • Ingår i: Journal of clinical medicine. - : MDPI AG. - 2077-0383. ; 11:12
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: The main goal of this post hoc analysis of the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study was to evaluate the rate of short- and long-term infectious and non-infectious complications occurring after ASCT in patients with multiple myeloma (MM). Methods: The analysis included all patients with MM from the CALM study who underwent ≥1 ASCT. The primary endpoint of the analysis was to determine the rate of infectious and non-infectious complications after ASCT and to compare them in three time periods: 0–100 days, 101 days–1 year, and >1 year after the first transplant. Results: The analysis included a total of 3552 patients followed up for a median of 56.7 months (range 0.4–108.1). Complication rates decreased with the time from ASCT with 24.85 cases per 100 patient-years from day 0 to 100 days after the transplant, and <2.31 cases per 100 patient-years from the 101st day. At 100 days after ASC T, 45.7% of patients had complications, with infectious events being twice as frequent as non-infectious complications. Bacterial infections (6.5 cases per 100 patient-years, 95% CI: 6.1–7.0) and gastrointestinal complications (4.7 cases per 100 patient-years, 95% CI: 4.3–5.1) were the most common early events. The pattern of complications changed with time from ASCT. The presence of complications after ASCT was not associated with overall survival. Conclusions: Our data provide a solid basis for comparing ASCT-related complications to those caused by emerging treatments in multiple myeloma, such as CAR T-cell therapy and other immunotherapies.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-7 av 7

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy